ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1774

Citrullinated and Malondialdehyde-Acetaldehyde Co-Modified Fibrinogen Activates Macrophages and Induces Pro-Fibrotic shift in Coronary Endothelium Phenotype

Nozima Aripova1, Wenxian Zhou2, Hannah Johnson1, Michael Duryee1, Kimberley Sinanan1, Carlos Hunter1, Tate Johnson1, Mabruka Alfaidi1, Daniel Anderson3, Kishore Bidasee1, Geoffrey Thiele1 and Ted Mikuls1, 1University of Nebraska Medical Center, Omaha, NE, 2University of Nebraska Medical Center, Bellevue, NE, 30587964, Durham, NC

Meeting: ACR Convergence 2025

Keywords: Cardiovascular, Collagen, cytokines, macrophages, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (1770–1779) Cytokines & Cell Trafficking Poster

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Rheumatoid arthritis (RA) patients are at increased risk for developing heart failure with preserved ejection fraction (HFpEF), which is characterized by impaired left ventricular relaxation. The mechanisms underlying RA-associated HFpEF remain unclear, but pro-fibrotic pathways are well-characterized. Citrulline (CIT) and malondialdehyde-acetaldehyde (MAA) are post-translational modifications (PTMs) that serve as autoantigens in RA. These mediators synergistically activate macrophages via NFkB and p38 signaling, leading to pro-inflammatory and pro-fibrotic responses in vitro. Our laboratory recently demonstrated that PTMs are over-expressed and co-localized in the cardiac tissues of RA-HF compared to non-RA HF patients. The objective of this study is to investigate whether cardiac fibrosis is also increased in RA-HF patients and to identify whether PTMs induce a pro-fibrotic responses in human coronary artery endothelial cells (HCAECs).

Methods: Left ventricular (LV) apex tissues from RA-HF patients (n=3) and age- and sex-matched non-RA HF controls (n=3) were stained with Masson’s trichrome. Cardiac fibrosis was measured by quantifying collagen deposition using ImageJ and analyzed using Student’s t test. In separate experiments, human U-937 monocytes (source) were differentiated into macrophages (Fig. 1). Macrophages were pre-incubated for 1 hr with either 1 μM BIRB-796 (p38 inhibitor), 50 μM BAY-11-7085 (NF-κB inhibitor), or media control. After that, macrophages were stimulated with 25 μg/mL of either unmodified fibrinogen (FIB) or PTM co-modified fibrinogen (FIB-MAA-CIT) for 48 hours. After stimulation, supernatants were collected and applied to HCAECs for 24 hours. HCAEC mRNA was isolated, and expression of fibrotic mediators (SMAD3, ACTA2, PDGF) was quantified by qRT-PCR. Fibrotic mediator expression was then compared using one-way ANOVA followed by Tukey’s post hoc test.

Results: Patients with RA-HF exhibited significantly increased perivascular fibrosis (p< 0.05) and a non-significant trend toward increased interstitial fibrosis (p=0.18) compared to non-RA HF controls (Fig. 2). Supernatants from FIB-MAA-CIT–stimulated macrophages significantly upregulated mRNA expressions of SMAD3, ACTA2, and PDGFB in HCAECs compared to FIB (p< 0.001). Pre-treatment with p38 or NF-κB inhibitors brought pro-fibrotic gene expression back to baseline levels (Fig. 3).

Conclusion: Our findings suggest that PTM–activated macrophages secrete soluble factors that induce marked pro-fibrotic responses in HCAECs. Those soluble factors are potentially contributing to increased collagen deposition, suggested by perivascular fibrosis observed in RA-HF cardiac tissues. Macrophage activation via p38 and NF-κB pathways appears critical in this process. Targeting PTMs or their downstream signaling pathways may represent a novel therapeutic strategy to attenuate HF burden in RA.

Supporting image 1Methods set up.

Supporting image 2Trichrome stain measuring collagen deposition in human heart tissues. Cardiac tissues from non-RA controls (non-RA HF controls) and RA patients (RA-HF) with Heart Failure (n=3/group). Collagen deposition (blue) were quantified using with Fiji plug-in and mean values from 3 images/patient calculated. Images were taken around blood vessels (perivascular fibrosis) and between cardiomyocytes (interstitial fibrosis). Representative image of 20X frame at left ventricle apex was shown. Data shown on graphs are mean ± standard deviation. Student’s t test was performed, and statistical differences were shown in *: * p < 0.05.

Supporting image 3PCR measuring pro-fibrotic markers in HCAEC cells following stimulation with macrophage supernatants. Macrophage supernatants were collected post antigen stimulation (FIB or FIB-MAA-CIT) in the presence or absence of inhibitors (p38i or NFkBi). HCAEC gene expression was measured post 24-hour incubation for A) SMAD3, B) ACTA2, and C) PDGF. One-way ANOVA was performed and the statistical differences were shown in *: * p < 0.05; *** p < 0.001; **** p < 0.0001.


Disclosures: N. Aripova: None; W. Zhou: None; H. Johnson: None; M. Duryee: None; K. Sinanan: None; C. Hunter: None; T. Johnson: None; M. Alfaidi: None; D. Anderson: None; K. Bidasee: None; G. Thiele: None; T. Mikuls: Amgen, 2, 5, Merck/MSD, 1, Olatech Therapeutics, 1, UCB, 1.

To cite this abstract in AMA style:

Aripova N, Zhou W, Johnson H, Duryee M, Sinanan K, Hunter C, Johnson T, Alfaidi M, Anderson D, Bidasee K, Thiele G, Mikuls T. Citrullinated and Malondialdehyde-Acetaldehyde Co-Modified Fibrinogen Activates Macrophages and Induces Pro-Fibrotic shift in Coronary Endothelium Phenotype [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/citrullinated-and-malondialdehyde-acetaldehyde-co-modified-fibrinogen-activates-macrophages-and-induces-pro-fibrotic-shift-in-coronary-endothelium-phenotype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/citrullinated-and-malondialdehyde-acetaldehyde-co-modified-fibrinogen-activates-macrophages-and-induces-pro-fibrotic-shift-in-coronary-endothelium-phenotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology